vs
Side-by-side financial comparison of Dexcom (DXCM) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.0× StoneX Group Inc.). Dexcom runs the higher net margin — 21.2% vs 11.6%, a 9.6% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 21.6%). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).
DXCM vs SNEX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $267.3M | $139.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 15.4% |
| Net Margin | 21.2% | 11.6% |
| Revenue YoY | 21.6% | 81.0% |
| Net Profit YoY | 153.6% | 63.3% |
| EPS (diluted) | $0.67 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $32.7B | ||
| Q2 25 | $1.2B | $851.2M | ||
| Q1 25 | $1.0B | $820.4M | ||
| Q4 24 | $1.1B | $663.1M | ||
| Q3 24 | $994.2M | $31.1B | ||
| Q2 24 | $1.0B | $571.8M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $139.0M | ||
| Q3 25 | $283.8M | $85.7M | ||
| Q2 25 | $179.8M | $63.4M | ||
| Q1 25 | $105.4M | $71.7M | ||
| Q4 24 | $151.7M | $85.1M | ||
| Q3 24 | $134.6M | $76.7M | ||
| Q2 24 | $143.5M | $61.9M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | 3.7% | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | 3.0% | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 15.4% | ||
| Q3 25 | 20.1% | 0.3% | ||
| Q2 25 | 18.4% | -1.3% | ||
| Q1 25 | 12.9% | -1.0% | ||
| Q4 24 | 17.0% | -3.2% | ||
| Q3 24 | 15.3% | -0.0% | ||
| Q2 24 | 15.7% | -4.7% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 11.6% | ||
| Q3 25 | 23.5% | 0.3% | ||
| Q2 25 | 15.5% | 7.4% | ||
| Q1 25 | 10.2% | 8.7% | ||
| Q4 24 | 13.6% | 12.8% | ||
| Q3 24 | 13.5% | 0.2% | ||
| Q2 24 | 14.3% | 10.8% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $2.50 | ||
| Q3 25 | $0.70 | $0.72 | ||
| Q2 25 | $0.45 | $1.22 | ||
| Q1 25 | $0.27 | $1.41 | ||
| Q4 24 | $0.37 | $1.69 | ||
| Q3 24 | $0.34 | $2.32 | ||
| Q2 24 | $0.35 | $1.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.5B |
| Total Assets | $6.3B | $47.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.6B | ||
| Q3 25 | $1.8B | $1.6B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $904.9M | $1.3B | ||
| Q4 24 | $606.1M | $1.4B | ||
| Q3 24 | $621.2M | $1.3B | ||
| Q2 24 | $939.2M | $1.2B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.5B | ||
| Q3 25 | $2.7B | $2.4B | ||
| Q2 25 | $2.6B | $2.0B | ||
| Q1 25 | $2.3B | $1.9B | ||
| Q4 24 | $2.1B | $1.8B | ||
| Q3 24 | $2.0B | $1.7B | ||
| Q2 24 | $2.4B | $1.6B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $47.8B | ||
| Q3 25 | $7.5B | $45.3B | ||
| Q2 25 | $7.3B | $34.3B | ||
| Q1 25 | $6.8B | $31.3B | ||
| Q4 24 | $6.5B | $29.6B | ||
| Q3 24 | $6.4B | $27.5B | ||
| Q2 24 | $6.8B | $25.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.3B |
| Free Cash FlowOCF − Capex | — | $-1.3B |
| FCF MarginFCF / Revenue | — | -106.4% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | — | -9.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $-1.3B | ||
| Q3 25 | $659.9M | $3.5B | ||
| Q2 25 | $303.0M | $1.5B | ||
| Q1 25 | $183.8M | $-154.5M | ||
| Q4 24 | $301.4M | $-477.8M | ||
| Q3 24 | $199.5M | $192.6M | ||
| Q2 24 | $279.4M | $-622.1M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $-1.3B | ||
| Q3 25 | $579.4M | $3.5B | ||
| Q2 25 | $208.9M | $1.5B | ||
| Q1 25 | $96.8M | $-169.8M | ||
| Q4 24 | $176.8M | $-491.4M | ||
| Q3 24 | $88.3M | $175.9M | ||
| Q2 24 | $213.3M | $-640.5M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -106.4% | ||
| Q3 25 | 47.9% | 10.7% | ||
| Q2 25 | 18.1% | 173.3% | ||
| Q1 25 | 9.3% | -20.7% | ||
| Q4 24 | 15.9% | -74.1% | ||
| Q3 24 | 8.9% | 0.6% | ||
| Q2 24 | 21.2% | -112.0% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.3% | ||
| Q3 25 | 6.7% | 0.1% | ||
| Q2 25 | 8.1% | 1.9% | ||
| Q1 25 | 8.4% | 1.9% | ||
| Q4 24 | 11.2% | 2.1% | ||
| Q3 24 | 11.2% | 0.1% | ||
| Q2 24 | 6.6% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | -9.08× | ||
| Q3 25 | 2.33× | 41.18× | ||
| Q2 25 | 1.69× | 23.52× | ||
| Q1 25 | 1.74× | -2.15× | ||
| Q4 24 | 1.99× | -5.61× | ||
| Q3 24 | 1.48× | 2.51× | ||
| Q2 24 | 1.95× | -10.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
